TRENTON, N.J. (AP) - Federal regulators say they've approved new suppliers for two crucial cancer drugs, easing critical shortages - at least for the time being - that have patients worried about missing life-saving treatments.
The Food and Drug Administration will temporarily allow importation of a replacement drug for Doxil, a drug for ovarian and other cancers that hasn't been available for new patients for months.
The agency also has approved another supplier for a preservative-free version of methotrexate, a crucial drug for children with a type of leukemia and for high-dose treatment of bone cancer.
2 On Your Side did a story last week about a local girl who relies on methotrexate to treat her cancer.
The FDA increasingly has been able to prevent drug shortages by getting advance notice from manufacturers, but about 280 drugs currently are in short supply.